Sharadha Devi Gunasekaran

Sharadha Devi Gunasekaran practices at Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health.

Sharadha Devi Gunasekaran's NPI, 1912373929, was assigned on August 12, 2015. Sharadha Devi Gunasekaran holds Pennsylvania license MD70049.

Sharadha Devi Gunasekaran's primary practice is Allegheny General Hospital, at 320 East North Avenue, Pittsburgh, PA 15212 in Allegheny County. The practice phone is (412) 359-3131.

Sharadha Devi Gunasekaran's primary practice is Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI also links Sharadha Devi Gunasekaran to 1 more breast imaging center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sharadha Devi Gunasekaran practices, 2 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Sharadha Devi Gunasekaran's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dmand AI has Sharadha Devi Gunasekaran's licenses on file in 3 states: Pennsylvania, Michigan and Minnesota.

CMS data shows 75 Medicare services from Sharadha Devi Gunasekaran across 4 procedure codes in 2024, for 184 Medicare patients. Medicare paid $5,018 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 184 Medicare patients who saw Sharadha Devi Gunasekaran in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sharadha Devi Gunasekaran's median patient age at 70, with 40% women.

In 2018, Sharadha Devi Gunasekaran wrote 35 Medicare Part D claims. Every claim was for a generic drug. They cover 2 drugs, with $681 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Sharadha Devi Gunasekaran for performance year 2024, reported through an alternative payment model (APM). Sharadha Devi Gunasekaran accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Sharadha Devi Gunasekaran from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Edwards Lifesciences Corporation paid the most, $51.